Last updated on February 2018

A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome


Brief description of study

This is a Randomized, open-label, 2 groups, parallel design.

Detailed Study Description

This study objective is to compare the safety and efficacy between fixed dose combination (Duowell tab) and free pill combination therapy of Telmisartan and Rosuvastatin in hypertensive and hypercholesterolemic patients with metabolic syndrome.

Clinical Study Identifier: NCT02968160

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.